re:mission

Friends it has been an emotional week for sure. Many of you have shared our excitement on social media, but in case you missed the massive announcement on Tuesday, Seattle Children’s announced that 20 out of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed acute lymphoblastic leukemia (ALL) have achieved complete remission.

Then on Wednesday the Seattle Times published this amazing front page article, featuring our sweet friend Meagan. I literally had to take a picture of it in an attempt to grasp the enormity of what is happening.

seattle times

Our huge congratulations to Dr. Michael Jensen, Dr. Rebecca Gardner and the entire team at the Ben Towne Center for Childhood Cancer Research. This is an incredible milestone! Furthermore, since earlier this year when the FDA allowed this clinical trial to give a larger dosage of T cells this team is batting 100% in the treatment of children with relapsed ALL. It is truly beyond anyone’s expectations.

Your generosity has made this possible. The investment early on of Ben Towne Foundation supporters, along with the team at the Center, made the pre-clinical trial research possible to take this work to the FDA and then of course to these children and young adults. It is not very often, if at all, that your time and money legitimately go towards something that is saving lives. But it has. Twenty of them and counting. And for that we are grateful.

Happy Friday,
Carin and Jeff

PS – Our benefit manager Courtney also gave birth this week to a baby girl – another reason to celebrate! Congratulations Courtney and Mark!